Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1

Interventions

Cisplatin 44 Paclitaxel 21 Radiotherapy 20 Brachytherapy 19 Carboplatin 18 Bevacizumab 7 Drug Therapy 6 camrelizumab 5 toripalimab 4 nimotuzumab 4 Radiation 4 Neoadjuvant Therapy 4 Gemcitabine 4 tislelizumab 3 sintilimab 3 pembrolizumab 3 apatinib 3 Vaccines 3 TP protocol 3 Surgical Procedures, Operative 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 nedaplatin 2 fludarabine 2 endostar protein 2 anlotinib 2 Topotecan 2 Surveys and Questionnaires 2 Sentinel Lymph Node Biopsy 2 Radiotherapy, Intensity-Modulated 2 Mindfulness 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Uterine Cervical Neoplasms × brivanib × Clear all

NCT04395612 2021-05-21

CQGOG0101

Chongqing University Cancer Hospital

Phase 2 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡